Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

Susanna Hallberg Björn EvertssonEllen LillvallMalin BoremalmPierre de FlonYunzhang WangJonatan Salzer Jan N Lycke Katharina Fink Thomas FrisellFaiez Al NimerAnders Svenningsson

Published in: European journal of neurology (2024)

Accumulated dose and time on rituximab treatment are associated with a modest but significant decline in immunoglobulin levels. Previous MS therapies may influence additional IgG decline.

Keyphrases

multiple sclerosis
diffuse large b cell lymphoma
mass spectrometry
ms ms
hodgkin lymphoma
white matter